| VEXMX | VNVNX | VEXMX / VNVNX | |
| Total Expense Ratio | 0.19 | 0.85 | 22% |
| Annual Report Gross Expense Ratio | 0.19 | 0.92 | 21% |
| Fund Existence | 39 years | 13 years | - |
| Gain YTD | 15.259 | 22.349 | 68% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 93.7B | 233M | 40,215% |
| Annual Yield % from dividends | 0.90 | 0.29 | 310% |
| Returns for 1 year | 28.23 | -1.48 | -1,907% |
| Returns for 3 years | 69.12 | 14.62 | 473% |
| Returns for 5 years | 28.76 | -8.49 | -339% |
| Returns for 10 years | 198.33 | 25.70 | 772% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBT | 230.60 | 0.81 | +0.35% |
| First Trust NYSE Arca Biotech ETF | |||
| ZTR | 6.73 | 0.01 | +0.15% |
| Virtus Total Return Fund | |||
| RSPE | 33.42 | -0.11 | -0.32% |
| Invesco ESG S&P 500 Equal Weight ETF | |||
| PRCS | 27.51 | -0.40 | -1.42% |
| Parnassus Core Select ETF | |||
| PBEU | 32.72 | -0.47 | -1.42% |
| Portfolio Building Block Eur Bks Idx ETF | |||